Regulation of endothelin synthesis in hepatic endothelial cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 274, Issue 6 37-6, 1998, Pages

  Eakes, Ann T ^a   Olson, Merle S ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Kupffer cell; Lipopolysaccharide; Liver; Transforming growth factor

Indexed keywords

ENDOTHELIN; LIPOPOLYSACCHARIDE; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; ENDOTHELIUM CELL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; IMMUNOREACTIVITY; KUPFFER CELL; LIVER CELL; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; STATISTICAL ANALYSIS; VASOCONSTRICTION;

EID: 0031776019     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1998.274.6.g1068     Document Type: Article

References (59)

1. Bissell, D. M., S. S. Wang, W. R. Jarnagin, and F. J. Roll. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J. Clin. Invest. 96: 447-455, 1995.
2. Brooks, D. P., L. C. Contino, B. Storer, and E. H. Ohlstein. Increased endothelin excretion in rats with renal failure induced by partial nephrectomy. Br. J. Pharmacol. 104: 987-989, 1991.
3. Casey, M. L., R. A. Word, and P. C. MacDonald. Endothelin-1 gene expression and regulation of endothelin mRNA and protein biosynthesis in avascular human amnion. Potential source of amniotic fluid endothelin. J. Biol. Chem. 266: 5762-5768, 1991.
4. Cernacek, P., and D. J. Stewart. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem. Biophys. Res. Commun. 161: 562-567, 1989.
5. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
6. Cristiani, C., D. Volpi, A. Landonio, and F. Bertolero. Endothelin-1-selective binding sites are downregulated by transforming growth factor-beta and upregulated by basic fibroblast growth factor in a vascular smooth muscle-derived cell line. J. Cardiovasc. Pharmacol. 23: 988-994, 1994.
7. Dallas, S. L., S. Park-Snyder, K. Miyazono, D. Twardzik, G. R. Mundy, and L. F. Bonewald. Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. J. Biol. Chem. 269: 6815-6821, 1994.
8. De Bleser, P. J., T. Niki, V. Rogiers, and A. Geerts. Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J. Hepatol. 26: 886-893, 1997.
9. Eakes, A. T., S. A. K. Harvey, and M. S. Olson. Endothelin association with cultured rat hepatic endothelial cells: functional characterization. Biochim. Biophys. Acta 1359: 153-164, 1997.
10. Eakes, A. T., K. M. Howard, J. E. Miller, and M. S. Olson. Endothelin-1 production by hepatic endothelial cells: characterization and augmentation by endotoxin exposure. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G605-G611, 1997.
11. Estrada, C., C. Gomez, and C. Martin. Effects of TNF-alpha on the production of vasoactive substances by cerebral endothelial and smooth muscle cells in culture. J. Cereb. Blood Flow Metab. 15: 920-928, 1995.
12. 125I-lipopolysaccharide by isolated rat Kupffer cells. Hepatology 8: 1550-1554, 1988.
13. Fujitani, Y., K. Oda, M. Takimoto, T. Inui, T. Okada, and Y. Urade. Autocrine receptors for endothelins in the primary culture of endothelial cells of human umbilical vein. FEBS Lett. 298: 79-83, 1992.
14. Gandhi, C. R., R. H. Behal, S. A. K. Harvey, T. A. Nouchi, and M. S. Olson. Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes. Biochem. J. 287: 897-904, 1992.
15. Gandhi, C. R., K. Stephenson, and M. S. Olson. Endothelin, a potent peptide agonist in the liver. J. Biol. Chem. 265: 17432-17435, 1990.
16. G-monomethyl-L-arginine by transforming growth factor-β 1 in conscious, normal, but not endotoxaemic, rats. Br. J. Pharmacol. 116: 3042-3048, 1995.
17. Golden, C. L., J. P. Kohler, H. S. Nick, and G. A. Visner. Effects of vasoactive and inflammatory mediators on endothelin-1 expression in pulmonary endothelial cells. Am. J. Respir. Cell Mol. Biol. 12: 503-512, 1995.
18. Goto, M., Y. Takei, S. Kawano, K. Nagano, S. Tsuji, E. Masuda, Y. Nishimura, S. Okumura, T. Kashiwagi, H. Fusamoto, and T. Kamada. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology 19: 675-681, 1994.
19. Hahn, A. W., T. J. Resink, T. Scott-Burden, J. Powell, Y. DoM, and F. R. Buhler. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul. 1: 649-659, 1990.
20. Harada, M., H. Itoh, O. Nakagawa, Y. Ogawa, Y. Miyamoto, K. Kuwahara, E. Ogawa, T. Igaki, J. Yamashita, I. Masuda, T. Yoshimasa, I. Tanaka, Y. Saito, and K. Nakao. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy. Evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 96: 3737-3744, 1997.
21. Hewett, J. A., and R. A. Roth. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol. Rev. 45: 382-411, 1993.
22. Horie, M., S. Uchida, M. Yanagisawa, Y. Matsushita, K. Kurokawa, and E. Ogata. Mechanisms of endothelin-1 mRNA and peptides induction by TGF-β and TPA in MDCK cells. J. Cardiovasc. Pharmacol. 17: S222-S225, 1991.
23. Housset, C., D. C. Hockey, and D. M. Bissell. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc. Natl. Acad. Sci. USA 90: 9266-9270, 1993.
24. Kaddoura, S., N. P. Curzen, T. W. Evans, J. D. Firth, and P. A. Poole-Wilson. Tissue expression of endothelin-1 mRNA in endotoxaemia. Biochem. Biophys. Res. Commun. 218: 641-647, 1996.
25. Kinoshita, A., T. Tamura, C. Aoki, T. Nakanishi, S. Sobue, F. Suzuki, K. Takahashi, and M. Takigawa. Demonstration of endothelin (ET) receptors on cultured rabbit chondrocytes and stimulation of DNA synthesis and calcium influx by ET-1 via its receptors. Cell Biol. Int. 19: 647-654, 1995.
26. Knook, D. L., and E. C. Sleyster. Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp. Cell Res. 99: 444-449, 1976.
27. Kojima, M., K. Ohata, and H. Yasue. Structural organization and chromosomal assignment of the swine endothelin-1 gene. J. Vet. Med. Sci. 59: 431-435, 1997.
28. Kubota, T., M. Taguchi, K. Kobayashi, M. Masuda, and T. Aso. Relationship between the release of prolactin and endothelin-1 in human decidualized endometrial cells. Eur. J. Endocrinol. 137: 200-204, 1997.
29. Kurihara, H., M. Yoshizumi, T. Sugiyama, F. Takaku, M. Yanagisawa, T. Masaki, M. Hamaoki, H. Kato, and Y. Yazaki. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem. Biophys. Res. Commun. 159: 1435-1440, 1989.
30. Lundblad, R., and K. E. Giercksky. Endothelin concentrations in experimental sepsis: profiles of big endothelin and endothelin 1-21 in lethal peritonitis in rats. Eur. J. Surg. 161: 9-16, 1995.
31. Manthey, C. L., T. Kossmann, J. B. Allen, M. L. Corcoran, M. E. Brandes, and S. M. Wahl. Role of Kupffer cells in developing streptococcal cell wall granulomas. Streptococcal cell wall induction of inflammatory cytokines and mediators. Am. J. Pathol. 140: 1205-1214, 1992.
32. Margulies, K. B., F. L. Hildebrand, Jr., A. Lerman, M. A. Perrella, and J. C. Burnett, Jr. Increased endothelin in experimental heart failure. Circulation 82: 2226-2230, 1990.
33. Marra, F., L. F. Bonewald, S. Park-Snyder, I. S. Park, K. A. Woodruff, and H. E. Abboud. Characterization and regulation of the latent transforming growth factor-beta complex secreted by vascular pericytes. J. Cell. Physiol. 166: 537-546, 1996.
34. Marsden, P. A., and B. M. Brenner. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am. J. Physiol. 262 (Cell Physiol. 31): C854-C861, 1992.
35. Masaki, T. Endothelins: homeostatic and compensatory actions in the circulatory and endocrine systems. Endocr. Rev. 14: 256-268, 1993.
36. Masaki, T., S. Kimura, M. Yanagisawa, and K. Goto. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 84: 1457-1468, 1991.
37. Matsumura, Y., S. Murata, K. Takada, M. Takaoka, and S. Morimoto. Involvement of transforming growth factor-beta 1 for platelet-induced stimulation of endothelin-1 production. Clin. Exp. Pharmacol. Physiol. 21: 991-996, 1994.
38. Mustafa, S. B., C. R. Gandhi, S. A. K. Harvey, and M. S. Olson. Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells. Hepatology 21: 545-553, 1995.
39. Mustafa, S. B., K. M. Howard, and M. S. Olson. Platelet-activating factor augments lipopolysaccharide-induced nitric oxide formation by rat Kupffer cells. Hepatology 23: 1622-1630, 1996.
40. Myhre, U., J. T. Pettersen, C. Risoe, and K. E. Giercksky. Endothelin-1 and endotoxemia. J. Cardiovasc. Pharmacol. 22: S291-S294, 1993.
41. Nagelkerke, J. F., K. P. Barto, and T. J. Van Berkel. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J. Biol. Chem. 258: 12221-12227, 1983.
42. Nakamura, T., K. Kasai, Y. Sekiguchi, N. Banba, K. Takahashi, T. Emoto, Y. Hattori, and S. Shimoda. Elevation of plasma endothelin concentrations during endotoxin shock in dogs. Eur. J. Pharmacol. 205: 277-282, 1991.
43. Pannen, B. H., M. Bauer, J. X. Zhang, J. L. Robotham, and M. G. Clemens. Endotoxin pretreatment enhances portal venous contractile response to endothelin-1. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H7-H15, 1996.
44. Rieder, H., G. Ramadori, and K. H. Meyer zum Buschenfelde. Sinusoidal endothelial liver cells in vitro release endothelin - augmentation by transforming growth factor beta and Kupffer cell-conditioned media. Klin. Wochenschr. 69: 387-391, 1991.
45. Roland, C. R., J. A. Goss, M. J. Mangino, D. Hafenrichter, and M. W. Flye. Autoregulation by eicosanoids of human Kupffer cell secretory products. A study of interleukin-1, interleukin-6, tumor necrosis factor-α, transforming growth factor-β, and nitric oxide. Ann. Surg. 219: 389-399, 1994.
46. Ros, J., A. Leivas, W. Jimenez, M. Morales, M. Bosch-Marce, V. Arroyo, F. Rivera, and J. Rodes. Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells. J. Hepatol. 26: 81-87, 1997.
47. Sakurai, T., M. Yanagisawa, A. Inoue, U. S. Ryan, S. Kimura, Y. Mitsui, K. Goto, and T. Masaki. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem. Biophys. Res. Commun. 175: 44-47, 1991.
48. Sarphie, T. G., D. S. Nb, and I. V. Deaciuc. Kupffer cell inactivation prevents lipopolysaccharide-induced structural changes in the rat liver sinusoid: an electron-microscopic study. Hepatology 23: 788-796, 1996.
49. Schnermann, J. B., X. L. Zhu, X. Shu, T. Yang, Y. G. Huang, M. Kretzler, and J. P. Briggs. Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-beta. Endocrinology 137: 5000-5008, 1996.
50. Stephenson, K., C. R. Gandhi, and M. S. Olson. Biological actions of endothelin. Vitam. Horm. 48: 157-198, 1994.
51. Stephenson, K., S. A. K. Harvey, S. B. Mustafa, A. T. Eakes, and M. S. Olson. Endothelin association with the cultured rat Kupffer cell: characterization and regulation. Hepatology 22: 896-905, 1995.
52. Sugiura, M., T. Inagami, and V. Kon. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun. 161: 1220-1227, 1989.
53. Tatrai, A., S. Foster, P. Lakatos, G. Shankar, and P. H. Stern. Endothelin-1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures. Endocrinology 131: 603-607, 1992.
54. Van Berkel, T. J. C. Functions of hepatic non-parenchymal cells. In: Metabolic Compartmentation, edited by H. Sies. London: Academic, 1981, p. 437-482.
55. Van Bossuyt, H., R. B. De Zanger, and E. Wisse. Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. J. Hepatol. 7: 325-337, 1988.
56. Yamada, G., H. Hama, Y. Kasuya, T. Masaki, and K. Goto. Possible sources of endothelin-1 in damaged rat brain. J. Cardiovasc. Pharmacol. 26: S486-S490, 1995.
57. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells [see comments]. Nature 332: 411-415, 1988.
58. Zhang, J. X., W. Pegoli, Jr., and M. G. Clemens. Endothelin-1 induces direct constriction of hepatic sinusoids. Am. J. Physiol. 266 (Gastrointest. Liver Physiol. 29): G624-G632, 1994.
59. Zhou, W., W. Chao, B. A. Levine, and M. S. Olson. Role of platelet activating factor in hepatic responses after bile duct ligation in rats. Am. J. Physiol. 263 (Gastrointest. Liver Physiol. 26): G587-G592, 1992.